# clm_95A2A8BB89F6

subject: Merck & Co. (/record/merck.md)  
predicate: quarterly_research_and_development  
value: 1,862,000,000 United States dollar  
valid_from: 2012-03-31  
valid_to: 2012-06-30  
published: 2012-05-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_5897CB0342BB  
last_updated: 2026-11-08  
cite: AsOf. "Merck & Co. quarterly research and development: 1,862,000,000 United States dollar", as of 2012-03-31 (until 2012-06-30). Claim clm_95A2A8BB89F6, https://asof.is/claim/clm_95A2A8BB89F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2012, filed 2012-05-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/310158/000119312512216683/0001193125-12-216683-index.htm (primary, SEC EDGAR 10-Q Q1 FY2012, published 2012-05-08)

## Supersedes

- [Merck & Co.](/record/merck.md) | quarterly_research_and_development | 1,954,000,000 United States dollar | valid 2011-09-30 to 2012-03-31 | conf 0.95 | superseded | superseded_by [clm_95A2A8BB89F6](/claim/clm_95A2A8BB89F6.md) | [clm_1F7AAAEEBAA8](/claim/clm_1F7AAAEEBAA8.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.